Beta-Agonist Lung injury TrIal-2 (BALTI-2) : a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome
Bookmark
ShareCopied to clipboardBeta-Agonist Lung injury TrIal-2 (BALTI-2) : a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome is a book. It was written by S. Gates and published by NIHR Journals Library in 2013.
Key facts
- author: S. Gates
- publication date: 2013
- book publisher: NIHR Journals Library
- book series: Health technology assessment
- book subjects: Placebos (Medicine), Clinical trials-Great Britain
See more factsExtract data
Download datasets about Beta-Agonist Lung injury TrIal-2 (BALTI-2) : a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome:
Dataset of books series that contain Beta-Agonist Lung injury TrIal-2 (BALTI-2) : a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome:
Dataset of book subjects that contain Beta-Agonist Lung injury TrIal-2 (BALTI-2) : a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome:
"Beta-Agonist Lung injury TrIal-2 (BALTI-2) : a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome" is one of the books by S. Gates, books by NIHR Journals Library and 2,617,384 books in our database.
Related
Connected or similar to Beta-Agonist Lung injury TrIal-2 (BALTI-2) : a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome: .
This dashboard is based on data from: The British Library.
This content is available under the CC BY 4.0 license.